🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06253962
Recruiting Observational

Carotid Atherosclerosis in Predicting Coronary Artery Disease

NCT06253962 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai Zhongshan Hospital
Phase
Observational
Started
2024-02-10
Last updated
2024-02-12

Condition(s) studied

Carotid AtherosclerosisCoronary Atheroscleroses

Investigational drug(s) / intervention(s)

coronary agiongraphy

coronary agiongraphy: severity of coronary atherosclerosis

Study summary

Carotid plaque burden and composition features, particularly lipid necrotic core, are significantly associated with severity of CAD stenosis. This study aims to explore the relationship between various phenotypic patterns of carotid atherosclerosis with the prevalence, phenotype, and severity of coronary atherosclerosis. The patients with chest tightness or chest pain will receive carotid artery ultrasonography before coronary angiography so as to explore the relationship between them.

Eligibility

Sex
ALL
Min age
14 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: * patients receive carotid ultrasound and coronary angiography Exclusion Criteria: * None

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
180 Fenglin Road Shanghai China Recruiting

More Shanghai Zhongshan Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06253962 on ClinicalTrials.gov ↗ ← All trials in China